<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Kinesiophobia in Systemic Sclerosis: Relationship With Functional Status, Pulmonary Fibrosis, Depression, and Other Clinical Parameters

dc.contributor.authorCanan Balamir Pehlivan
dc.contributor.authorMustafa Akif Sariyildiz
dc.contributor.authorRemzi Cevik
dc.contributor.authorSerkan Erbatur
dc.contributor.authorIbrahim Batmaz
dc.date.accessioned2025-06-30T05:33:21Z
dc.date.available2025-06-30T05:33:21Z
dc.date.issued2025-05
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractBackground: The aim of this study was to evaluate the levels of kinesiophobia and its relationship with functional status, quality of life, pulmonary involvement, depression, and other clinical parameters of the disease in patients with systemic sclerosis (SSc). Methods: A total of 100 individuals (40 patients with SSc and 60 healthy controls) were included in the study. The Tampa scale was used to assess kinesiophobia. Beck Depression Inventory (BDI) was used to assess depression. Scleroderma Health Assessment Questionnaire (SSc-HAQ) was used to assess functional status. Modified Rodnan skin score was used to assess skin thickness, and high-resolution computed tomography was used to assess lung fibrosis. Results: The mean Tampa kinesiophobia score was significantly higher in patients with SSc compared to healthy controls. Depressive symptoms were present in 57.5% of patients with SSc. Disease duration, pain, fatigue, disease activity, functional status, pulmonary fibrosis, and depressive symptoms were correlated with kinesiophobia in patients with SSc. Conclusion: There is an increased prevalence of kinesiophobia in patients with SSc, which seems to be more closely associated with disease duration, pain levels, and depressive symptoms. Articles © The authors | Journal compilation
dc.identifier.citationPehlivan, C. B., Sariyildiz, M. A., Cevik, R., Erbatur, S., & Batmaz, I. (2025). Kinesiophobia in Systemic Sclerosis: Relationship With Functional Status, Pulmonary Fibrosis, Depression, and Other Clinical Parameters. Journal of Clinical Medicine Research, 17(5), 256.
dc.identifier.doi10.14740/jocmr6202
dc.identifier.issn1918-3003
dc.identifier.issn1918-3011
dc.identifier.issue5
dc.identifier.pmid40503069
dc.identifier.scopus2-s2.0-105007310000
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://hdl.handle.net/20.500.12604/8720
dc.identifier.volume17
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorPehlivan, Canan Balamir
dc.publisherElmer Press, Inc.
dc.relation.ispartofJournal of Clinical Medicine Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Başka Kurum Yazarı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDepression
dc.subjectDisease activity
dc.subjectKinesiophobia
dc.subjectPulmonary fibrosis
dc.subjectSystemic sclerosis
dc.titleKinesiophobia in Systemic Sclerosis: Relationship With Functional Status, Pulmonary Fibrosis, Depression, and Other Clinical Parameters
dc.typeArticle
oaire.citation.issue5
oaire.citation.volume17

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Canan-Balamir Pehlivan-2025.pdf
Boyut:
322,37 KB
Biçim:
Adobe Portable Document Format

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1,17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: